Opinions
Kim Bolton
DataMetrex AI Limited
DM-X
DON'T BUY
Oct 13, 2022
Supports health and safety. Problem is they continue to lose money. Hit by rising interest rates. (Analysts’ price target is $0.25)
$0.085
Stock price when the opinion was issued
Financial Services
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
HOLD
RISKY
The strategy to build into block chain in Korea and bring it back to Canada could be a good one – not knowing the exact specifics. You want exposure to the big players and you know it will become material when the chartered banks have departments now focusing on the new payment technology.
Financial Services
COMMENT
Well before COVID-19 the diagnostic space was very credible. It is an interesting one. There is a strong recurring revenue component to it. There will be a desire to upgrade countries' medical ability. This will be an interesting space moving forward and so he wants to take a closer look at it.
Financial Services
DON'T BUY
He looks for proven business models, high returns on invested capital, low debt, capable management, asset light, and increasing shareholder wealth. This company's been around a couple of years, trading at 13 cents, so he has no idea. Speculative/gambling. He wouldn't touch it for his clients.
Financial Services
DON'T BUY
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company has a small market cap and is quite volatile. It is a technology-focused company with exposure to artificial intelligence and machine learning. It currently has negative cash flow. 5i does not endorse it. Unlock Premium - Try 5i Free
Financial Services
BUY
Advertising